Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 18 - Sayı: 6

Evaluation of ventricular repolarization features with novel electrocardiographic parameters (Tp-e, Tp-e/QT) in patients with psoriasis

Pages
397–401
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, these patients should be more closely screened for ventricular arrhythmias.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Psoriasis is a chronic inflammatory disorder, which affects around 1%-3% of the human population worldwide.
📊
Key Findings & Data:Some studies have reported that psoriasis is related to increased arrhythmias.
💡
Conclusion & Impact:Therefore, these patients should be more closely screened for ventricular arrhythmias.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Psoriasis is a chronic inflammatory disorder, which affects around 1%-3% of the human population worldwide. Cardiovascular events are the leading cause of morbidity and mortality in patients with psoriasis. Some studies have reported that psoriasis is related to increased arrhythmias. The Tp-e interval and Tp-e/QT ratio have been accepted as new markers for the assessment of myocardial repolarization and ventricular arrhythmogenesis. The aim of this study was to assess ventricular repolarization in patients with psoriasis using Tp-e interval and Tp-e/QT ratio.Methods: The study population consisted of 74 patients with psoriasis and 74 healthy volunteers. The diagnosis of psoriasis was based on a clinical or histopathological examination of all patients. QT interval, corrected QT (QTc), QT dispersion (QTd), Tp-e interval, corrected Tp-e, and Tp-e/QT ratio were measured from the 12-lead electrocardiogram. These parameters were compared between groups.Results: According to the electrocardiographic parameters, QT and QTc intervals and QTd were significantly higher in patients with psoriasis than in control subjects (p<0.001; p<0.001; p=0.014; respectively). The Tp-e interval, corrected Tp-e, and Tp-e/QT ratio were significantly higher in patients with psoriasis than in control subjects [93±13 milliseconds (ms) vs. 98±14 ms, p=0.040; 104±17 ms vs. 111±17 ms, p=0.008; 0.23±0.03 vs. 0.25±0.03, p<0.001; respectively]. Additionally, the CRP value was an independent predictor of an increased Tp-e/QT ratio (?=0.537, p< 0.001).Conclusion: Our study revealed that ventricular repolarization features were impaired in patients with psoriasis. Therefore, these patients should be more closely screened for ventricular arrhythmias.

🔖

Cite This Article

ARISOY, A., KARAMAN, K., KARAYAKALI, M., DEMİRELLİ, S., SEÇKİN, H. Y., ÇELİK, A., CEYHAN, K. (2017). Evaluation of ventricular repolarization features with novel electrocardiographic parameters (Tp-e, Tp-e/QT) in patients with psoriasis. The Anatolian Journal of Cardiology, Cilt: 18 - Sayı: 6, 397–401. https://ajindex.com/articles/366834

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Schön MP, Boehncke WH. Psoriasis. Engl Med 2005; 352: 1899- 912. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, [luintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as risk for cardiovascular disease. Clin Chim Acta 2001; 303: 33-9. Yeung H,Takeshita J, Mehta NN, Kimmel SE, 0gdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: population-based study. JAMA Dermatol 2013; 149: 1173-9.
  2. Markuszeski L, Bissinger A, Janusz l, Narbutt J, Jedrzejowska AS, Zalewska A. Heart rate and arrhythmia in patients with psoriasis vuIgaris. Arch Med Res 2007; 38: 64-9. AhIehoff 0, Gislason GH, Jızırgensen CH, Lindhardsen J, CharIot M, Olesen JB, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: Danish Nationwide Cohort Study. Eur Heart 2012; 33: 2054- 64. Proietti I, Raimondi G, Skroza N, Pampena R, Bernardini N, La Viola G, et al. Cardiovascular risk in psoriatic patients detected by heart rate variability (HRVI analysis. Drug Dev Res 2014: 75: 81-4.
  3. Bacaksız A, Erdoğan E, Tasal A, Vatankulu MA, KuI S, Sevgili E, et al. Electrocardiographic wave characteristics in patients with psoriasis vulgaris. Ups Med Sci 2013; 118: 35-41.
  4. Castro Hevia J, Antzelevitch C, Tornés Barzaga F, Dorantes Sanchez M, Doıticos BaIea F,Zayas Molina R, et al. Tpeak-Tend and TpeakTend dispersion as risk factors for ventriculartachycardia/ventricuIarfibriIIation in patients with the Brugada syndrome. Am Coll Cardiol 2006; 47: 1828-34.
  5. Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu VV, etal. Does Tpeak-Tend provide an index of transmural dispersion of repoIarization? Heart Rhythm 2007; 4: 1114--6. Feldman SR. quantitative definition of severe psoriasis for use in clinical trials. Dermatolog Treat 2004; 15: 27-9.
  6. Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: systematic review and meta-analysis of observational studies. Am Heart Assoc 2013; 2: e000062. Liu T, Li G. Is atrial fibrillation an inflammatory disease? Med Hypotheses 2005; 64: 1237-8.
  7. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: meta-analysis. Am Coll Cardiol 2007; 49: 1642- 8. Thomsen NH, HorsIev-Petersen K, Beyer JM. Ambulatory 24-hour continuous electrocardiographic monitoring in 54 patients with ankylosing spondylitis. Eur HeartJ 1986; 7: 240-6. L